BiomEdit
Company

Last deal

Amount

Grant

Stage

02.11.2023

Date

3

all rounds

$44.M

Total amount

General

About Company
BiomEdit develops probiotics and bioactives for animal health.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2022

Number of employees

Last funding type

Grant

IPO status

Private

Description

BiomEdit utilizes a unique platform that combines high-throughput sequencing and data analytics to rapidly discover and screen novel probiotic species and bioactive molecules. These can be engineered to enhance production of beneficial metabolites or expression of immune modulating proteins, providing the next generation of antibiotic-free animal health products. Their technology aims to address unmet needs in animal agriculture and food security by leveraging the potential of the microbiome, improving animal protein production and livestock disease monitoring.
Contacts

Phone number

Social url